Torrent Pharmaceuticals announced that the USFDA issued a Form 483 with one procedural observation after inspecting its Pithampur manufacturing facility. The inspection took place from September 16-20. Torrent Pharma will respond within the prescribed timeframe and collaborate closely with the USFDA to address the observation. Shares of Torrent Pharma rose by 2.97% on BSE.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.